AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. - Test2 - elhamkhani - TriplyDB

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.

http://www.wikidata.org/entity/Q34988406

about

Lithium: the pharmacodynamic actions of the amazing ion Review of pharmacological treatment in mood disorders and future directions for drug development.Dopamine receptors - IUPHAR Review 13 A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests Advancing drug discovery for schizophrenia.Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders A new avenue for lithium: intervention in traumatic brain injury.Role of the axonal initial segment in psychiatric disorders: function, dysfunction, and intervention A high-throughput screen for Wnt/β-catenin signaling pathway modulators in human iPSC-derived neural progenitors.Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia.Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation.Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities.Lithium ions attenuate serum-deprivation-induced apoptosis in PC12 cells through regulation of the Akt/FoxO1 signaling pathways.Molecular Signatures of Psychosocial Stress and Cognition Are Modulated by Chronic Lithium Treatment.A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorder.Lithium increases proliferation of hippocampal neural stem/progenitor cells and rescues irradiation-induced cell cycle arrest in vitro.Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders.STAT3-mediated coincidence detection regulates noncanonical immediate early gene induction.Translation: screening for novel therapeutics with disease-relevant cell types derived from human stem cell models.Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene.Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder.Lithium's role in neural plasticity and its implications for mood disorders The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment.New Repeat Polymorphism in the AKT1 Gene Predicts Striatal Dopamine D2/D3 Receptor Availability and Stimulant-Induced Dopamine Release in the Healthy Human Brain.Genetic Deletion of Akt3 Induces an Endophenotype Reminiscent of Psychiatric Manifestations in Mice.Fine-Tuning of the RIG-I-Like Receptor/Interferon Regulatory Factor 3-Dependent Antiviral Innate Immune Response by the Glycogen Synthase Kinase 3/β-Catenin Pathway Inhibition of GSK3 by lithium, from single molecules to signaling networks.A rare schizophrenia risk variant of CACNA1I disrupts CaV3.3 channel activity.Integrated transcriptome and methylome analysis in youth at high risk for bipolar disorder: a preliminary analysis Lithium Reversibly Inhibits Schwann Cell Proliferation and Differentiation Without Inducing Myelin Loss.An emerging role for Wnt and GSK3 signaling pathways in schizophrenia.A Role for Phosphodiesterase 11A (PDE11A) in the Formation of Social Memories and the Stabilization of Mood.Lithium and bipolar disorder: Impacts from molecular to behavioural circadian rhythms.Ketamine up-regulates a cluster of intronic miRNAs within the serotonin receptor 2C gene by inhibiting glycogen synthase kinase-3.Development of [18F]Maleimide-Based Glycogen Synthase Kinase-3β Ligands for Positron Emission Tomography Imaging.Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures.Lithium-associated transcriptional regulation of CRMP1 in patient-derived olfactory neurons and symptom changes in bipolar disorder.

P2860

Q22241779-39644BD5-7DD9-4785-BFE7-D7C6DEE9E979 Q26853509-89240AB2-9902-4E39-9DC0-A133086EAB0F Q28256783-CDF798EA-7EF5-433A-A285-D18EEE83ED2D Q28535325-1C3615F5-4FB0-4D74-BD48-88867A163C4B Q30448547-BD514A74-801F-41DB-AF46-3783B69CCC6E Q30474415-D1345CB7-02DC-4916-A3B7-138EE2703ADE Q33777958-BF49537E-0745-4E35-92E2-297EADA2AA1C Q33777980-BD91F4D7-7387-498D-8286-D22ED007B8C9 Q34071914-62205183-36D1-45DD-B0D6-6D75F3C1604A Q34393969-036EF2F9-5A3F-4DBF-BC74-1F24E1E072D3 Q35197367-65E6FDE1-1167-452E-932E-D31E3A78283C Q35505900-93D30CC7-2D94-4A3E-BAEB-7CC45ACBC12C Q35557270-ED49F864-3F73-467D-930B-3126321A25A1 Q35634683-2C0984C0-4331-4804-819F-504EC90A5999 Q35857649-C56EEC36-0844-4B6E-AE6C-CCF471967B1A Q35880985-87E42A08-628E-44D7-B2F5-EE26FCFD76CE Q36043355-23E9B47B-6D4C-4187-B444-70538E71BC23 Q36545682-8A626B0B-04F3-442A-A3E3-1909E26A349C Q36769080-DCA64736-1846-472C-9073-C2E885BF8043 Q36796847-8B62F875-2FAE-4DE1-985B-9A3AF8802BE0 Q37275071-E9196A3A-9DB7-48C6-8A11-24666FD7B48B Q37347610-DA75F1A9-23FE-4EB3-8F83-4263CBE9E7A2 Q37981491-BD2764C8-9FBD-478F-8D5D-DB841E40C393 Q37982704-C4F0D77D-E555-4ACA-BDC7-B375646E8D85 Q38101644-6B82C61F-9A03-42CC-8CB2-7F8329342E02 Q38189780-FF36A8A0-AFED-47E3-88F5-A538F4E0ACC0 Q38729316-1083E195-1C35-4352-82FE-38C07D2C204C Q38819941-93E40FF1-2D00-4DB8-A6A2-5ECA61A6555B Q38861095-18759CED-A6B8-4F0A-A698-E3EE5A31DEB4 Q41285005-A07B2157-124E-4207-A97D-A573A0E31699 Q41497165-462E4AC1-F210-498D-84B5-5F70F75A4D9A Q42124521-5D4912A8-119F-42D6-87E4-F0CDF736A1AF Q42502625-EC275A54-7A68-40B6-80C2-441A97A71F3C Q46956051-1AC72A0C-0E58-412F-AC91-02CB751D70FC Q47147373-5BC0B2AE-D555-4608-B161-BAEF2CE74374 Q47875065-2AA261C1-C69D-4CB8-BDDC-6B20FD59F570 Q48039552-B8B5B153-39FF-4F8D-BD66-E2ABBD157C14 Q48247868-9DA670DF-BFF2-4DC2-A490-AF615A69C3CB Q50734440-F96BF1A1-75AD-4302-8430-827D1ABD3EDD Q52582071-292827C5-8665-4BAC-A56A-BC534DAA93E9

P2860

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.

http://www.wikidata.org/entity/Q34988406

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.

@ast

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.

@en

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.

@nl

type

label

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.

@ast

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.

@en

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.

@nl

prefLabel

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.

@ast

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.

@en

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.

@nl

P1433

Q34988406-1B6DF31D-6B89-425B-9B8F-2957988462BE

P1476

Q34988406-FC0B2D1C-6AE8-4E66-A575-2ED3CCDE8464

P2093

Q34988406-19C8D3F7-3682-4A74-B9F1-CC697EF34428

Q34988406-31D3FD22-B04E-46A5-BF93-8E78EDCE7982

Q34988406-31F91CE0-0A18-4ED8-9C41-9D4D61070273

Q34988406-356FA514-6297-4DA1-A307-1DB7EF5A2404

Q34988406-389EFB6C-0B51-477D-9669-0AD0C863B2F7

Q34988406-45FB560D-38F1-4C94-9846-40103792BFB5

Q34988406-9E1DD28D-C3AB-45F2-BAF7-61F38AAC39E4

Q34988406-A693F6F1-5DF8-466B-B34C-9043E74EDC83

Q34988406-BD55E786-8331-453B-9A8E-9ECD97D7228C

Q34988406-E0294FE3-2265-4D61-9AD1-C3976E3BA363

P2860

Q34988406-002DCC8E-2116-4571-AA4B-C92A894A2607

Q34988406-0B94F137-9D06-4439-9BD1-733158436BBE

Q34988406-16E07DE4-2880-4F6C-BC87-0E744DDFEC55

Q34988406-1E05E0AB-4E0D-4FE1-8935-C2BD5D74992D

Q34988406-20D04275-BDF7-496A-BEC6-11ED313B1148

Q34988406-219AF54B-4D00-44C8-9F55-CBBDDB6F4799

Q34988406-23339EA5-566E-43C3-A6DA-7F67700C1E3B

Q34988406-265AC959-1E92-4F0D-B105-9810579559BF

Q34988406-2FF16097-1A22-4E9B-B98E-FBEEA0941CC8

Q34988406-37BEE52C-3B2E-439A-9F0E-41C9ED4473F8

P2888

Q34988406-4A4EB574-22AF-4435-A167-880DBDE15867

P304

Q34988406-D9C0C1F9-6521-42F4-90D9-70A0061B208B

P31

Q34988406-C6A1A413-7D6D-491D-BA52-90A2A06E1985

P356

Q34988406-3376E25D-0C27-4704-8FCB-B75F3A55C0ED

P407

Q34988406-12681C7F-C59E-463C-861D-3145FB691820

P433

Q34988406-0A2E4B0C-7A5F-4069-B9DB-395C6DDF4CBA

P478

Q34988406-AB051086-3246-4DC9-9BDD-4FC47699D674

P50

Q34988406-DBADB3B0-30C7-46C6-8809-370717D3E646

Q34988406-F3953F8C-8E76-42EF-939B-1B3576E15C23

P577

Q34988406-353DF844-51A1-4A91-8810-F6F7EBA8BE49

P5875

Q34988406-3C7E1052-A057-4332-BFB2-F44817A2EAE1

P6179

Q34988406-A7131641-627C-4764-BC8C-2623E1FD50D2

P698

Q34988406-086508FF-85DE-4AAC-86AC-E51999F3C042

P932

Q34988406-703619D4-4301-47B1-B231-781EE86D82E2

P356

P1433

Neuropsychopharmacology

P1476

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice

@en

P2093

Edward B Holson

http://www.w3.org/2001/XMLSchema#string

Edward M Scolnick

http://www.w3.org/2001/XMLSchema#string

Elizabeth L Clore

http://www.w3.org/2001/XMLSchema#string

Erin Berry-Scott

http://www.w3.org/2001/XMLSchema#string

Florence F Wagner

http://www.w3.org/2001/XMLSchema#string

Jen Q Pan

http://www.w3.org/2001/XMLSchema#string

Josh K Ketterman

http://www.w3.org/2001/XMLSchema#string

Keenan R Richards

http://www.w3.org/2001/XMLSchema#string

Michael C Lewis

http://www.w3.org/2001/XMLSchema#string

Misha Riley

http://www.w3.org/2001/XMLSchema#string

P2860

A beta-arrestin 2 signaling complex mediates lithium action on behavior

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

A molecular mechanism for the effect of lithium on development

The selectivity of protein kinase inhibitors: a further update

Lithium salts in the treatment of psychotic excitement

Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs

Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo

Inositol phosphates and cell signalling

A small molecule-kinase interaction map for clinical kinase inhibitors

Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium

P2888

P304

1397-1411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2011.24

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Randall T. Moon

Tracey L Petryshen

P577

2011-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50352001

http://www.w3.org/2001/XMLSchema#string

P6179

1053330359

http://www.w3.org/2001/XMLSchema#string

P698

21389981

http://www.w3.org/2001/XMLSchema#string

P932

3096809

http://www.w3.org/2001/XMLSchema#string